A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)

NCT00231790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

848

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence

Interventions

DRUG: MK-0634 50 mg
DRUG: MK-0634 125 mg
DRUG: Placebo for MK-0634

Sponsor

Merck Sharp & Dohme LLC